Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodies
Authors:
Top Cited Papers
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- U.S. Department of Energy
- National Institute of Allergy and Infectious Diseases
- Office of Science (W-31-109-Eng-38)
- Small Business Innovation Research
- Basic Energy Sciences
- Vaccine Research Center
This publication has 60 references indexed in Scilit:
- Snake three-finger α-neurotoxins and nicotinic acetylcholine receptors: molecules, mechanisms and medicineBiochemical Pharmacology, 2020
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Structure of the Native Muscle-type Nicotinic Receptor and Inhibition by Snake Venom ToxinsNeuron, 2020
- MolProbity: More and better reference data for improved all‐atom structure validationProtein Science, 2017
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- Isolation and pharmacological characterisation of papuantoxin-1, a postsynaptic neurotoxin from the venom of the Papuan black snake (Pseudechis papuanus)Biochemical Pharmacology, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Molecular Evolution and Phylogeny of Elapid Snake Venom Three-Finger ToxinsJournal of Molecular Evolution, 2003
- Conservation of neural nicotinic acetylcholine receptors from Drosophila to vertebrate central nervous systems.The EMBO Journal, 1988
- A monoclonal antibody which recognized the functional site of snake neurotoxins and which neutralizes all short‐chain variantsFEBS Letters, 1986